+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
531099 CENTUPLE

Centuple Global Share Price

 

 

Centuple Global live price: ₹39.5. It opened at ₹37 vs previous close ₹37; intraday high/low: ₹40/₹37. The 50 & 200 DMA stand at ₹46.62/₹58.87.

Centuple Global Performance

  • Today's Low
  • ₹37
  • Today's High
  • ₹40
  • 52 Week Low
  • ₹23
  • 52 Week High
  • ₹144
  • Open Price₹37
  • Previous Close₹37
  • Volume1,161
  • 50 DMA₹46.62
  • 100 DMA₹55.97
  • 200 DMA₹58.87

Centuple Global Chart

Investment Returns

  • Over 1 Month -4.01%
  • Over 3 Month -24.27%
  • Over 6 Month -63.08%
  • Over 1 Year + 68.23%

Smart Investing Starts Here Start SIP with Centuple Global for Steady Growth!

Invest Now

Centuple Global Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 22
  • P/B Ratio
  • 10.5
  • Average True Range
  • 3.59
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.98
  • RSI
  • 41.25
  • MFI
  • 25.81

Centuple Global Financials

Centuple Global Technicals

EMA & SMA

Current Price
₹39.50
+ 2.26 (6.07%)
pointer
  • Bearish Moving Average 12
  • Bullish Moving Average 4
  • 20 Day
  • ₹40.90
  • 50 Day
  • ₹46.60
  • 100 Day
  • ₹56.00
  • 200 Day
  • ₹58.90

Resistance and Support

38.28 Pivot Speed
  • R3 43.32
  • R2 41.53
  • R1 40.07
  • S1 36.82
  • S2 35.03
  • S3 33.57

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Centuple Global Ltd has an operating revenue of Rs. 573.81 Cr. on a trailing 12-month basis. An annual revenue growth of 114662% is outstanding, Pre-tax margin of 0% needs improvement, ROE of 72% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 19 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 93 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Centuple Global Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-30 Audited Results
2026-05-23 Others Inter-alia, to consider 1. Approve regularisation of Mr. Gaurav Kaushik & Mr. Ashish Jain as a NonExecutive Independent Director. 2. Appointment of New Secretarial Auditor. 3. Other business matters.
2026-03-18 Others Inter-alia, to consider 1. Resignation of Non- Executive Independent Director of the Company. 2. Appointment of Non- Executive Independent Director of the Company.
2026-02-25 Others Inter-alia, to consider : 1. Resignation of Mr. Kumar Anubhav Upadhyay (DIN: 09519842), as Whole-Time Director. 2. Appointment of Mr. Anuj Kumar Agarwal (DIN: 08572887) as Whole-Time Director.
2026-01-28 Quarterly Results

Centuple Global Shareholding Pattern

0%
8.59%
77.08%
14.33%

Centuple Global FAQs

Centuple Global share price is ₹39 As on 20 June, 2026 | 09:13

The Market Cap of Centuple Global is ₹21.6 Cr As on 20 June, 2026 | 09:13

The P/E ratio of Centuple Global is 14.3 As on 20 June, 2026 | 09:13

The PB ratio of Centuple Global is 10.5 As on 20 June, 2026 | 09:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23